As of November 7, 2026, Medline Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from July 9, 2026 to October 15, 2026, naming 1 departure. The latest filing names Joseph P. Baratta, leaving (Form 8-K, October 15, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Medline Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Medline Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-07-09 to 2026-10-15. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Medline Inc. files it.
Also on the record for Medline Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 6, 2026 | Stake report, Schedule 13G/A, by GIC Private Limited | 8.49% of the class | 5%+ stakes | Source |
| October 30, 2026 | Stake report, Schedule 13G/A, by GIC Private Limited | 13.03% of the class | 5%+ stakes | Source |
| August 11, 2026 | Stake report, Schedule 13G/A, by Hellman & Friedman Investors X, L.P. | 16% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G/A, by BMA VIII L.L.C. | 16.5% of the class | 5%+ stakes | Source |
| August 6, 2026 | Stake report, Schedule 13G, by FMR LLC | 5.5% of the class | 5%+ stakes | Source |
| May 26, 2026 | IPO filing, Form 424B4 | — | IPO filings | Source |
| May 20, 2026 | IPO filing, Form S-1 | — | IPO filings | Source |
| May 15, 2026 | Stake report, Schedule 13G/A, by Carlyle Group Inc. | 20.6% of the class | 5%+ stakes | Source |
| May 7, 2026 | Stake report, Schedule 13G/A, by Abu Dhabi Investment Authority | 4.9% of the class | 5%+ stakes | Source |
| May 6, 2026 | Stake report, Schedule 13G/A, by Hellman & Friedman Investors X, L.P. | 19.8% of the class | 5%+ stakes | Source |
| May 1, 2026 | Stake report, Schedule 13G/A, by BMA VIII L.L.C. | 20.6% of the class | 5%+ stakes | Source |
| March 6, 2026 | IPO filing, Form 424B4 | $29 a share | IPO filings | Source |
Selling to them or working with them? See who runs Medline Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Medline Inc. and the records around it.
Medline Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- IPO filing May 2026
- Who owns it
Companies that share a holder
- Abu Dhabi Investment Authority also filed stake reports on 7 other companies: Jersey Mike's Subs Inc. (Oct 2026), Eikon Therapeutics, Inc. (Oct 2026), AGL Private Credit Income Fund (Sep 2026)
- BX Mozart ML-2 Holdco L.P. also filed stake reports on 7 other companies: Corebridge Financial, Inc. (Nov 2026), Jersey Mike's Subs Inc. (Nov 2026), VARAGON CAPITAL CORPORATION (Oct 2026)
- Carlyle Group Inc. also filed stake reports on 7 other companies: SunPower Inc. (Aug 2026), Q32 Bio Inc. (Jul 2026), StandardAero, Inc. (May 2026)
Watch Medline Inc.
Get an email when Medline Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Medline Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Medline Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Medline Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
14 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 23 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-15 | Out | 2026-12-31 | 8-K, 2026-10-15 | ||
| 2026-07-09 | Reported | not named in the filing | 8-K, 2026-07-09 |
New leaders reset buying decisions — get the Full Report on Medline Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Medline Inc., with the record behind each one.
Find candidates like senior executive at Medline Inc.Every change, in the filing's words
Departing: Joseph P. Baratta, effective 2026-12-31
On October 13, 2026, Joseph P. Baratta notified the Board of Directors (the "Board") of Medline Inc. (the "Company") of his decision to resign from the Board, effective as of December 31, 2026.
- Mr. Baratta's decision coincides with his previously announced departure from Blackstone Inc. and is not the result of any disagreement with the Company related to the Company's operations, policies, or practices.
- The Board is grateful for Mr. Baratta's service and contributions to the Company.
Reported
On July 7, 2026, Stephen L. Miller, Chief Operating Officer of Medline Inc. (the " Company "), notified the Company that he would retire from his role, effective August 30, 2026, for health-related reasons.
- The Company is launching a search for his successor.
Tools for this story
Each opens in a new tab, filled in for Medline Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.